Familial Hypercholesterolaemia as a Predisposing Factor for Atherosclerosis

被引:4
作者
Poznyak, Anastasia, V [1 ]
Litvinova, Larisa [2 ]
Poggio, Paolo [3 ]
Orekhov, Alexander N. [1 ,4 ]
Melnichenko, Alexandra A. [4 ]
机构
[1] Inst Atherosclerosis Res, Osennyaya 4-1-207, Moscow 121609, Russia
[2] Immanuel Kant Baltic Fed Univ, Ctr Immunol & Cellular Biotechnol, 6 Gaidara St, Kaliningrad 236001, Russia
[3] Ctr Cardiol Monzino IRCCS, Unit Study Aort Valvular & Coronary Pathol, Via Carlo Parea 4, I-20138 Milan, Italy
[4] Inst Gen Pathol & Pathophysiol, Lab Angiopathol, 8 Baltiiskaya St, Moscow 125315, Russia
基金
俄罗斯科学基金会;
关键词
lipid; cholesterol; hypercholesterolaemia; atherosclerosis; PCSK9; RISK; SIMVASTATIN; REDUCTION; CHILDREN; EFFICACY; THERAPY; LDLR;
D O I
10.3390/biomedicines10102639
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipid metabolism alterations are an important component of the pathogenesis of atherosclerosis. However, it is now clear that the atherogenesis process involves more than one mechanism, and more than one condition can predispose this condition. Multiple risk factors contribute to the atherosclerosis initiation and define its course. Familial hypercholesterolaemia is a disorder of lipid metabolism that often leads to atherosclerosis development. As is clear from the disease name, the hallmark is the increased levels of low-density lipoprotein cholesterol (LDL-C) in blood. This creates favourable conditions for atherogenesis. In this review, we briefly described the familial hypercholesterolaemia and summarized data on the relationship between familial hypercholesterolaemia and atherosclerosis.
引用
收藏
页数:12
相关论文
共 65 条
  • [1] Familial Hypercholesterolaemia Diagnosis and Management
    Alonso, Rodrigo
    Perez de Isla, Leopoldo
    Muniz-Grijalvo, Ovidio
    Luis Diaz-Diaz, Jose
    Mata, Pedro
    [J]. EUROPEAN CARDIOLOGY REVIEW, 2018, 13 (01) : 14 - 20
  • [2] Adults with familial hypercholesterolaemia have healthier dietary and lifestyle habits compared with their non-affected relatives: the SAFEHEART study
    Arroyo-Olivares, Raquel
    Alonso, Rodrigo
    Quintana-Navarro, Gracia
    Fuentes-Jimenez, Francisco
    Mata, Nelva
    Muniz-Grijalvo, Ovidio
    Diaz-Diaz, Jose L.
    Zambon, Daniel
    Arrieta, Francisco
    Garcia-Cruces, Jesus
    Garrido-Sanjuan, Juan A.
    Banegas, Jose R.
    Mata, Pedro
    [J]. PUBLIC HEALTH NUTRITION, 2019, 22 (08) : 1433 - 1443
  • [3] Telomere length as a potential biomarker of coronary artery disease
    Bhattacharyya, Joyeeta
    Mihara, Keichiro
    Bhattacharjee, Deborshi
    Mukherjee, Manjari
    [J]. INDIAN JOURNAL OF MEDICAL RESEARCH, 2017, 145 : 730 - 737
  • [4] Bin Saleh Fatemah S, 2022, Cureus, V14, pe27573, DOI 10.7759/cureus.27573
  • [5] Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert Panel
    Bjelakovic, Bojko
    Stefanutti, Claudia
    Reiner, Zeljko
    Watts, Gerald F.
    Moriarty, Patrick
    Marais, David
    Widhalm, Kurt
    Cohen, Hofit
    Harada-Shiba, Mariko
    Banach, Maciej
    [J]. JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [6] Familial Hypercholesterolemia
    Bouhairie, Victoria Enchia
    Goldberg, Anne Carol
    [J]. CARDIOLOGY CLINICS, 2015, 33 (02) : 169 - +
  • [7] Lipoprotein metabolism in familial hypercholesterolemia
    Chemello, Kevin
    Garcia-Nafria, Javier
    Gallo, Antonio
    Martin, Cesar
    Lambert, Gilles
    Blom, Dirk
    [J]. JOURNAL OF LIPID RESEARCH, 2021, 62
  • [8] Bile Acid Metabolism and Signaling
    Chiang, John Y. L.
    [J]. COMPREHENSIVE PHYSIOLOGY, 2013, 3 (03) : 1191 - 1212
  • [9] Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents
    Cohen, Hofit
    Stefanutti, Claudia
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (06)
  • [10] The Efficacy of Colesevelam HCl in the Treatment of Heterozygous Familial Hypercholesterolemia in Pediatric and Adult Patients
    Davidson, Michael
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (08) : 1247 - 1252